Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US09073M1045
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG000C15114
TECH
Bio-Techne Corp
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Biotechnology · THEMEFOLIO: $HLTH
NAME
Bio-Techne Corp
ISIN
US09073M1045
TICKER
TECH
MIC
XNAS
REUTERS
TECH.OQ
BLOOMBERG
TECH US
Di., 29.10.2024       Bio-Techne
US09073M1045

ST. PAUL, Minn., Oct. 29, 2024 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing and Bio-Techne Corporation (NASDAQ: TECH), today announced that Luminary Therapeutics has been awarded a $300,000 G-Rex® Grant. Luminary's G-Rex® Grant will enable expeditious process development and IND-enabling studies of several novel CAR...
Zur Nachricht
Bio-Techne
Charts & Research Termsheets Terminal
Permalink
Do., 10.10.2024       Bio-Techne
US09073M1045

MINNEAPOLIS, Oct. 10, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, October 30, 2024, at 8:00 a.m. CDT to review its first quarter fiscal 2025 financial results. Access to the discussion may be obtained as follows: Time: 8:00 a.m. CDT Date: October...
Zur Nachricht
Bio-Techne
Charts & Research Termsheets Terminal
Permalink
Mi., 09.10.2024       Bio-Techne
US09073M1045

Award will support clinical manufacturing of the Company's promising Neutrophil only Leukocyte Infusion Therapy (N-LIfT) platformST. PAUL, Minn., Oct. 9, 2024 /PRNewswire/ -- ScaleReady™, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady™, and LIfT BioSciences, ('LIfT' or 'the Company'), a rapidl...
Zur Nachricht
Bio-Techne
Charts & Research Termsheets Terminal
Permalink
Di., 08.10.2024       Bio-Techne
US09073M1045

ST. PAUL, Minn., Oct. 8, 2024 /PRNewswire/ -- ScaleReady™, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady™, today announced that Eric Tran, Ph.D, Associate Member of the Earle A. Chiles Research Institute, a division of the Providence Cancer Institute, has been awarded a G-Rex Grant. Dr. Tran'...
Zur Nachricht
Bio-Techne
Charts & Research Termsheets Terminal
Permalink
Mo., 07.10.2024       Bio-Techne
US09073M1045

ST. PAUL, Minn., Oct. 7, 2024 /PRNewswire/ -- ScaleReady™, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady™, today announced that Christopher A. Klebanoff, MD, a physician-scientist at Memorial Sloan Kettering Cancer Center (MSK) has been awarded a G-Rex® Grant.  Dr. Klebanoff's $300,000 G-Rex®...
Zur Nachricht
Bio-Techne
Charts & Research Termsheets Terminal
Permalink
Do., 26.09.2024       Bio-Techne
US09073M1045

MINNEAPOLIS , Sept. 26, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that one of its spatial biology brands, Lunaphore, is partnering with Discovery Life Sciences (Discovery) to add Lunaphore COMET™, a best-in-class spatial biology platform, to Discovery's global suite of biospecimen products and specialty lab servic...
Zur Nachricht
Bio-Techne
Charts & Research Termsheets Terminal
Permalink
Di., 24.09.2024       Bio-Techne
US09073M1045

MINNEAPOLIS, Sept. 24, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its portfolio of solutions advancing neuroscience research at the upcoming annual meeting of the Society for Neuroscience (SfN) at Neuroscience 2024, taking place October 5-9, 2024, in Chicago, Illinois....
Zur Nachricht
Bio-Techne
Charts & Research Termsheets Terminal
Permalink
Mi., 18.09.2024       Bio-Techne
US09073M1045

MINNEAPOLIS, Sept. 18, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today issued its 2024 Corporate Sustainability Report (CSR), detailing the continued progress advancing its Environmental, Social and Governance (ESG) initiatives. Bio-Techne's CSR is organized around four key pillars: Our People, Advancing Science, Governance and O...
Zur Nachricht
Bio-Techne
Charts & Research Termsheets Terminal
Permalink
Mi., 18.09.2024       Bio-Techne
US09073M1045

ST. PAUL, Minn., Sept. 18, 2024 /PRNewswire/ -- ScaleReady™, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady™, today announced that ImmunoScape Pte. Ltd. (a Singapore-U.S. based TCR-T therapy company) has been awarded a G-Rex® Grant.  ImmunoScape's $250,000 G-Rex® Grant will enable process deve...
Zur Nachricht
Bio-Techne
Charts & Research Termsheets Terminal
Permalink
Di., 17.09.2024       Bio-Techne
US09073M1045

PHILADELPHIA, Sept. 17, 2024 /PRNewswire/ -- Verismo Therapeutics, a clinical-stage CAR T company developing the novel KIR-CAR platform technology, today announced that it has been awarded a $150,000 G-Rex Grant by ScaleReady™. This grant will support Verismo Therapeutics' ongoing efforts to optimize the development and manufacturing of its KIR-C...
Zur Nachricht
Bio-Techne
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Di., 17.09.2024       Bio-Techne
US09073M1045

ST. PAUL, Minn., Sept. 17, 2024 /PRNewswire/ -- ScaleReadyTM, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH), and CellReadyTM, today announced that it has awarded a $150,000 G-Rex Grant to Verismo Therapeutics, a clinical-stage CAR T company developing the novel KIR-CAR platform technology.  This grant will...
Zur Nachricht
Bio-Techne
Charts & Research Termsheets Terminal
Permalink
Mo., 16.09.2024       Bio-Techne
US09073M1045

ST. PAUL, Minn., Sept. 16, 2024 /PRNewswire/ -- ScaleReady and Bio-Techne Corporation (NASDAQ: TECH) today announced the launch of the G-Rex optimized ProPakTM GMP Cytokines, ideally tailored to high efficiency closed system cell and gene-modified cell therapy (CGT) manufacturing. The ProPakTM GMP Cytokine product consists of a weldable bag fille...
Zur Nachricht
Bio-Techne
Charts & Research Termsheets Terminal
Permalink
Di., 27.08.2024       Bio-Techne
US09073M1045

ST. PAUL, Minn., Aug. 27, 2024 /PRNewswire/ -- ScaleReady™, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady™, today announced that Dr. Steve Feldman, Scientific Director and Site Head of Stanford Medicine's Laboratory for Cell and Gene Medicine (LCGM), has been awarded the inaugural G-Rex® Gran...
Zur Nachricht
Bio-Techne
Charts & Research Termsheets Terminal
Permalink
Mo., 26.08.2024       Bio-Techne
US09073M1045

MINNEAPOLIS, Aug. 26, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer will present at the following investor conferences: Morgan Stanley 22nd Annual Global Healthcare ConferenceSeptember 4, 20244:05 PM EDT 2024 Wells Fargo Healthcare ConferenceSeptember 6, 202411...
Zur Nachricht
Bio-Techne
Charts & Research Termsheets Terminal
Permalink
So., 18.08.2024       Bio-Techne
US09073M1045

Das Instrument TE1 US09073M1045 BIO-TECHNE CORP. DL-,01 EQUITY wird ex Dividende/Zinsen gehandelt am 19.08.2024 The instrument TE1 US09073M1045 BIO-TECHNE CORP. DL-,01 EQUITY has its ex-dividend/interest day on 19.08.2024...
Zur Nachricht
Bio-Techne
Charts & Research Termsheets Terminal
Permalink
Do., 15.08.2024       Bio-Techne
US09073M1045

Das Instrument TE1 US09073M1045 BIO-TECHNE CORP. DL-,01 EQUITY wird cum Dividende/Zinsen gehandelt am 16.08.2024 und ex Dividende/Zinsen am 19.08.2024 The instrument TE1 US09073M1045 BIO-TECHNE CORP. DL-,01 EQUITY has its pre-dividend/interest day on 16.08.2024 and its ex-dividend/interest day on 19.08.2024...
Zur Nachricht
Bio-Techne
Charts & Research Termsheets Terminal
Permalink